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Abstract 
Infection with Torque teno viruses (TTVs) is not restricted to humans. Different domestic and wild animal species are naturally infected with 
species-specific TTVs worldwide. Due to the global spread of the infection, it is likely that essentially all animals are naturally infected with 
species-specific TTVs, and that co-evolution of TTVs with their hosts probably occurred. Although TTVs are potentially related to many 
diseases, the evidence of the widespread infection in healthy human and nonhuman hosts raised doubts about their pathogenic potential. 
Nonetheless, their role as superimposed agents of other diseases or as triggers for impairment of immune surveillance is currently under 
debate. The possible contribution of animal TT viruses to interspecies transmission and their role as zoonotic agents are currently topics of 
discussion. 
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Introduction 
Anelloviruses (AVs) are a large group of small, 
non-enveloped viruses with a circular, single-stranded 
DNA genome of variable size, ranging from 2.1 to 3.8 
kb [1-3]. Because of their high degree of genetic 
heterogeneity, AVs are divided into at least 11 genera, 
each of them including a various number of species 
[4]. AVs are ubiquitous and highly prevalent 
worldwide [5,6]. They infect their hosts with multiple 
and often divergent strains [7,8] and are transmitted 
through multiple routes [9-15]. Infection with AVs 
probably occurs early in life [16] and leads to a 
progressive persistent infection of the natural host 
[17]. Human Torque teno virus (TTV) is the prototype 
of the Anelloviridae family, but a number of related 
viruses have been described in other mammalian hosts. 
Human TTV was originally reported in 1997 in a 
Japanese patient with post-transfusion, non-A-G 
hepatitis [18]. Since its discovery, a series of related 
human AVs have been characterized [19]. 
Furthermore, a series of closely related TTV-like 
viruses, and two distinct genera comprising viruses 
with smaller genome size and similar genetic 
organization, but only partial sequence homology, 
designated Torque teno midi virus (TTMDV) and 
Torque teno mini virus (TTMV), have been 
characterized [20-22]. A large number of AV species 
has also been reported in wild and domestic animals, 
including non-human primates, wild boars, badgers, 
pine martens, tupaias, rodents, bats, sea turtles, sea 
lions, livestock (pigs, sheep, cattle, camels, and 
poultry), and companion animals (cats and dogs) 
[3,5,23-29]. Indeed, since to date the presence of 
TTVs infecting mammalian species has been poorly 
investigated, it would not be surprising if all mammals 
were infected with species-specific TTVs. Human 
TTVs and TTVs infecting mammalian species have 
similar genomic and transcriptional organization, 
suggesting that co-evolution of TTVs with their hosts 
probably occurred [30]. However, AVs from different 
species share a low sequence homology, with genetic 
diversity varying between 35% (within genus) and 
56% (among genera) [19]. In particular, AVs infecting 
animal species are highly divergent from those 
detected in humans, both in sequence composition and 
genome length, although phylogenetically some 
animal TTVs cluster with the human TTVs [31]. 
Despite over 17 years of investigation, little is known 
about the pathogenesis and possible disease 
associations with AV infections, in part due to the lack 
of a robust cell culture system for viral replication or a 
suitable small-animal model. 
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Discovery and characterization of TTV 
In 1997, Nishizawa et al., using representational 
difference analysis, isolated a sequence of 500 
nucleotides from the blood of a patient suffering from 
a form of post-transfusion hepatitis of unknown 
etiology. The representative clone (N22) was found to 
originate from the genome of a non-enveloped, single-
stranded DNA virus, provisionally named TTV, the 
initials of the index patient [1,18]. Subsequent cloning 
and sequencing experiments conducted by Okamoto et 
al. led to the characterization of a linear genome of 
3,739 kb, called TA278 [1]. In 1999, the presence of a 
GC-rich sequence of approximately 120 nt was 
reported, allowing the recognition of the circular 
nature of the TTV genome with negative polarity [32]. 
The genomic full-length of the TA278 isolate was 
finally determined to be 3,853 nt, and the presence of 
the unique stem-and-loop structure in the GC-rich 
region was demonstrated [1,2]. Based on this and other 
structural and molecular characteristics that this virus 
shared with members of the family Circoviridae, and 
in particular with chicken anemia virus (CAV), TTV 
was initially recognized as the first human circovirus 
[32]. However, further studies showed no significant 
sequence identity between TTV and circovirus, and 
the virus was considered as the only representative of 
the new family Circinoviridae, from Latin circinatio, 
"circle" [2]. Shortly after the discovery, viral isolates 
were identified with genetic and structural 
characteristics similar to TTV, but with considerable 
genetic variability; among these, isolates PMV, 
SANBAN, and YONBAN [21,33] showed a 
nucleotide divergence greater than 50% compared to 
the prototype TA278. Subsequently, shorter sequences 
were isolated with genomic features intermediate 
between TTV and CAV; their characterization led to 
the identification of a new group of viruses named 
TTV-like mini virus (TTLMV, TTMV) [21]. Finally, 
in 2005, the International Committee on Taxonomy of 
Viruses (ICTV) proposed to classify TTMV and TTV 
into the new genus Anellovirus, and to assign to the 
acronym the meaning of Torque teno virus, from the 
Latin torque (necklace) and tenuis (narrow), referring 
to the characteristics of their genome [34]. TTV 
became the prototype of a large group of viral agents 
with similar genomic organization but a low sequence 
homology, isolated both in humans and in animals. In 
fact, in the following years, similar viruses were 
isolated in other species of vertebrates, including non-
human primates (chimpanzees, macaques, tamarin 
monkeys, and douroucouli), pets (dogs and cats), 
livestock (pigs, cattle, sheep, camels, and poultry), and 
wild boars, badgers, pine martens, tupaias, rodents, 
bats, sea turtles, and sea lions [3,5,23-29,35]. The 
natural infection of pigs was first described by Leary 
et al. in 1999 [5]; the first complete genome of Torque 
teno sus virus (TTSuV) was described by Okamoto in 
2002 [3]. In 17 years since discovery, over 200 
complete or partial sequences of viral genomes like 
TTV were characterized in humans and more than 10 
species of vertebrates. In 2009, the ICTV established 
the new family Anelloviridae, divided it into 11 
genera, each one with a different number of species. 
Three other genera, Mutorquevirus, Nutorquevirus, 
and Xitorquevirus, which include newly discovered 
isolates, are currently under consideration by the ICTV 
for inclusion within the family (Table 1). Human 
TTVs belong to the genus Alphatorquevirus, which 
includes 29 species. In addition to TTV, in humans 
there are two other TTV-like species: TTMV and 
TTMDV, classified within the family Anelloviridae 
and belonging to the genera Betatorquevirus and 
Gammatorquevirus, respectively. TTVs infecting pigs 
(Sus domesticus) include four species described so far: 
Torque teno sus virus 1a and 1b (TTSuV1a and 
TTSuV1b), belonging to the genus Iotatorquevirus, 
Table 1. Current classification of the Anelloviridae family [4] 
Genus Species Host 
Alphatorquevirus 29 Humans, chimpanzees 
Betatorquevirus 12 Humans, nonhuman primates 
Deltatorquevirus 1 Tupaia 
Epsilontorquevirus 1 Tamarin 
Etatorquevirus 2 Cats 
Gammatorquevirus 15 Humans, chimpanzees 
Iotatorquevirus 2 Swine 
Kappatorquevirus 2 Swine 
Lambdatorquevirus 1 Sea lions 
Thetatorquevirus 1 Dogs 
Zetatorquevirus 1 Douroucouli 
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and Torque teno sus virus k2a and k2b (TTSuVk2a 
and TTSuVk2b), the latter being the most recently 
discovered species, belonging to the genus 
Kappatorquevirus [36]. 
 
Structure and genomic organization of TTV 
The virus appears as a spherical particle with 
icosahedral symmetry and a diameter of 30–50 nm. 
The buoyant density in cesium chloride was found to 
be 1.31–1.33 g/cm3 for TTV in serum and 1.33–1.35 
g/cm
3
 for TTV in feces [2]. Resistance to treatment 
with detergents, solvents, and dry heat confirmed the 
absence of a lipid envelope [37,38]. TTV proteins 
have not been well characterized yet; however, similar 
to CAV, it is believed that the capsid is made up of a 
single structural protein. Sensitivity to DNase I, mung 
bean nuclease, and RNase A, and resistance to 
restriction enzyme NdeI have proven the single-
stranded nature of the viral DNA [2,37]. Hybridization 
with positive-sense RNA molecules and subsequent 
digestion has demonstrated the negative polarity of the 
viral DNA [2]. DNA size varies from 2.1 to 3.9 kb, 
depending on the host species [2,7,18,32]; in general, 
the sizes of the animal AVs are smaller than those of 
human AVs. TTVs infecting humans and chimps have 
a genome size ranging from 3.7 to 3.9 kb; the genome 
size of TTSuV (approximately 2.8 kb) is intermediate 
between the size of human TTV and the size of the 
smallest AV identified so far (< 2.1 kb), isolated in the 
cat [3]. Despite the variability in sequences and size, 
the various species of animal and human TTVs show 
similar genomic organization [3,24,39]. The genome 
consists of a coding region that contains at least three 
open reading frames (ORFs), and a non-translated 
region (UTR) of about 1.2 kb (0.8 kb in TTSuV), 
containing a GC-rich tract [40]. The highly conserved 
UTR region contains the TATA box and the polyA tail 
sequences and it is used as a transcription factor 
(Figure 1). The messenger RNAs (mRNAs) analyzed 
were transcribed from a plasmid containing the 
complete genome construct of TTV in COS1 cells 
[41]. Three spliced mRNAs of 3.0 kb, 1.2 kb, and 1.0 
kb with common 5’-and 3’-termini were recovered, 
and it was demonstrated that the splicing sites link 
distant ORFs to create two new ORFs capable of 
encoding 286 and 289 amino acids, respectively [41]. 
ORF1 encodes a product of about 700–770 amino 
acids, which is considered the viral capsid protein [3]. 
ORF2 codes for products of about 200 amino acids 
and in some genotypes it is divided into smaller 
ORF2a and ORF2b, the latter containing a CAV-like 
conserved amino acid motif, similar to protein-
tyrosine phosphatase, that is probably involved in 
cellular and/or viral protein regulation and processing 
during natural infection [42]. The product from ORF3 
is a protein of 285 amino acids with a serine-rich 
domain at the C-terminus, and it resembles the 
structure and function of the non-structural protein 5A 
of hepatitis C virus in suppressing the antiviral action 
of interferon [43]. A splicing-derived product of 105 
amino acids, called TTV-derived apoptosis-inducing 
protein, induces apoptosis in hepatocellular carcinoma 
cells, but it is absent in swine AVs. It is likely that 
intra-genomic rearrangements and alternative splicing 
events are responsible for the generation of other 
ORFs, at least in some genotypes [44].  
 
Replication of TTV 
The distribution of TTV in the tissues of the 
natural hosts and their detection in a wide variety of 
biological samples suggest that AVs are able to 
replicate in different cell types, recognizing receptors 
distributed across different tissues [45-47]. For DNA 
replication, similar to circovirus and in analogy to the 
plant and bacterial viruses with circular single-
stranded DNA, a rolling circle mechanism of 
replication has been proposed, leading to the formation 
of a circular, double-stranded intermediate [2]. As a 
DNA polymerase-coding sequence has never been 
demonstrated, it is believed that AVs, like most small 
DNA viruses, replicate their DNA using the DNA 
polymerase and the replication machinery of the host 
cell [48]. Replicating forms of the TTV genome have 
been detected in a variety of tissues, including lung, 
stimulated peripheral blood mononuclear cells, bone 
marrow, spleen, liver, pancreas, kidney, thyroid gland, 
and lymph nodes [45,49,50]. Furthermore, TTV was 
detected in the serum of most infected hosts. In bone 
marrow-derived cells, three types of mRNAs of TTV 
Figure 1. Genomic organization of TTV. Nucleotide positions 
refer to the TA278 isolate [91]. 
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(2.9 kb, 1.2 kb, and 1.0 kb) have been detected and 
produced by alternative splicing, as well as by 
transfecting African green monkey cells with whole 
TTV genome; in this case, at least six proteins derived 
from three distinct mRNAs, expressed from two 
different start codons, have been produced. 
 
Genetic variability of TTV 
Using conserved UTR-specific primers for 
detection of TTV DNA, several variants with high 
genetic diversity have been detected 
[7,21,32,35,51,52]. Human TTVs belonging to the 
genus Alphatorquevirus are divided into at least 29 
species and more than 40 genotypes and 70 subtypes, 
with nucleotide differences exceeding 50% among 
species, more than 30% between genotypes and 
between 15% and 29% among subtypes. The sequence 
homology between human and swine TTV is below 
45% [3,39,53]. Sequence homology between the 
TTSuV1 and TTSuV2 species was estimated to be 
around 56%, nucleotide divergence being higher 
among isolates of TTSuV1 (30%) compared to 
TTSuV2 isolates (15%). Genetic variability is greater 
in ORF1, where at least three hypervariable regions 
characterized by several insertions and deletions and 
amino acid diversity among TTV isolates higher than 
70% have been described. In TTV isolates belonging 
to the same genotype and in isolates belonging to 
different genotypes, at least 19 recombination sites 
have been identified, 13 of them located in the UTR 
[54]. Co-infection with strains of different genotypes 
is very frequent in humans [8,55], as is co-infection 
with viral subtypes and multiple species of TTSuV in 
swine [56]. Finally, it is possible that the interspecies 
transmission of TTVs between humans and livestock 
or pet animals may contribute to the genetic variability 
of the virus [30]. 
 
Animal TTVs 
TTV infection is not restricted to humans. Using 
highly conserved primers derived from the UTR of the 
TTV genome, a variety of TTV-like viruses have been 
detected in non-human primates and tupaias (tree 
shrews, Tupaia belangeri chinensis) [5,35,57]. The 
entire nucleotide sequences of species-specific TTVs 
that infect nonhuman primates, such as the 
chimpanzee (Pan troglodytes), Japanese macaque 
(Macaca fuscata), cotton-top tamarin (Saguinus 
oedipus), and douroucouli (Aotes trivirgatus) have 
been determined [24,35]. Human and simian TTVs 
share closely related genome organization and 
presumed transcriptional profiles, showing nearly 85% 
sequence similarity. However, it is now well 
established that TTV variants in nonhuman primates 
are species-specific [5,23,24,35,58] and that TTVs 
from macaques and tamarins are increasingly 
divergent from TTV variants infecting humans and 
chimpanzees [35]. Recent evidence shows that simian 
TTV can infect humans, as it has been observed that 
approximately 10% of Japanese patients with liver 
diseases are infected with simian TTV, although the 
mode of transmission of the infection from animals to 
humans has not been demonstrated [59]. Furthermore, 
TTV DNA has been detected in serum samples 
obtained from wild and domesticated animals, 
including chickens, pigs, wild boars, camels, cats, 
dogs, pine martens, sea lions, cows, and sheep [3,5]. 
Even more recently, Nishiyama et al. reported the 
identification of diverse anelloviruses in several 
species of wild rodents; the viruses are highly 
prevalent in wood mice (Apodemus sylvaticus) and 
field voles (Microtus agrestis), detectable at a low 
frequency in bank voles (Myodes glareolus), but 
absent from house mice (Mus musculus) [28]. The 
presence of TTV in dogs (now named Torque teno 
canis virus) has been documented, and the full-length 
nucleotide sequence of Japanese and Chinese isolate 
strains has also been reported; results indicate that 
dogs are naturally infected with species-specific TTVs 
with small genomic sizes and suggest a global 
distribution of TTVs with extremely divergent 
genomic sequences and lengths in animals [3,60]. In 
Italian dogs, the presence of Torque teno canis virus 
has recently been checked for, and about 10% of the 
animals were found to be infected with highly 
divergent variants (unpublished data). Indeed, since 
TTV has been detected in different animals, it might 
be considered as a zoonotic infection. Hence, it is 
possible that the virus can be transmitted from humans 
to animals and vice versa. Many recent studies have 
focused on TTVs that infect pigs (TTSuV). The AVs 
that infect swine, domestic pigs, and wild boars are 
spread all over the world, regardless of the race, age, 
gender, and state of health of the animals [30,61-63]. 
A recent retrospective study has documented the 
circulation of the virus in Spanish farms since 1985 
[64]. Globalization and international trade in live 
animals have been proven to play a crucial role in the 
spread of TTSuV [65]. In addition, the vast spread of 
the infection in swine and the absence of geographical 
clustering of the isolates have led some authors to 
speculate that the dissemination on a planetary scale 
may be partly due to the use of contaminated vaccines 
[13]. The global prevalence of infection varies 
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between 16.8% and 100% for TTSuV1 [66-68], and 
between 31% and 90% for TTSuV2 [63,66,69]. Data 
related to infection with TTSuVk2b, the most recently 
identified species, are still limited. A study on 244 pig 
serum samples from 17 different countries reported an 
overall 40% prevalence of infection [36], whereas 
Blois et al. reported an 11.5% prevalence of 
TTSuVk2b in 721 Italian pigs [70]. The high 
prevalence of TTSuV in the swine population 
indicates the existence of effective mechanisms of 
transmission. Although the fecal-oral route is 
considered the primary mode of transmission, other 
ways may contribute to the dissemination of the virus. 
TTSuVs have been found in the feces and in the nasal 
secretions of piglets in their first week of life; the 
prevalence of infection increases with age, and the 
virus is shed more through nasal secretions than 
through fecal elimination [71,72]. TTSuVs are also 
found in seminal fluid, indicating the possibility of 
sexual transmission of infection [73]. TTSuV DNA 
has also been found in colostrum and stillborn piglets, 
indicating that vertical and transplacental or intra-
uterine transmission may contribute to the 
dissemination of the virus [14]. So, infection with 
TTSuV occurs early in life and leads to a progressive 
persistent infection, with viremia levels increasing 
with the age of the animals. Most tissues and pig 
organs, if not all (brain, lungs, kidneys, bone marrow, 
heart, spleen, and mesenteric and mediastinal lymph 
nodes), test positive at five weeks of age, reaching the 
highest prevalence at slaughter [46]. In particular, 
lymphoid tissues and T lymphocytes are hypothesized 
to be the target site and the target cells for TTSuV, 
respectively [74]. As in humans, TTV shows a high 
degree of genetic variability in the swine population, 
and the presence of co-infection with multiple species 
and viral subtypes is a frequent event [39,56,75,76]. 
The production of antibodies elicited against the viral 
capsid protein, which is associated with a reduction in 
viremia, has been demonstrated [77], but these 
antibodies seem unable to eradicate the infection, 
which in part could explain the persistence of the virus 
in the animal host. Finally, the intra-uterine infection 
of the fetus before the acquisition of mature 
immunocompetence could explain the establishment 
of a state of immunotolerance against TTSuV [46].  
 
Innocent bystanders or something else? 
AVs have been known to exist for almost two 
decades and, although much is known about their 
epidemiology, they are orphan viruses still in search of 
a disease. The high prevalence of infection in the 
general population and the capability to establish 
persistent infections raised doubts about their actual 
pathogenic potential, and some researchers have 
considered TTV a component of the human microbiota 
[78]. Although TTV has been potentially related to 
many diseases, there are only a few reports supporting 
the disease-inducing potential of TTV. A series of 
studies suggest a possible involvement of human 
TTVs in the pathogenesis of certain diseases, such as 
hepatitis [79], hematological disorders [80], 
respiratory diseases [12], rheumatic autoimmune 
diseases [81], and various malignant disorders. 
Regarding AVs infecting animals, most studies to date 
have focused on the role of TTSuV in pig diseases. 
Although TTSuVs were found at particularly high 
frequency in healthy animals [70,72], they are 
currently receiving more attention due to the latest 
results on disease association. In fact, TTSuVs are 
considered non-pathogenic by themselves, but there is 
increasing evidence that points to their influence on 
the development of some diseases or suggests that 
these viruses even affect disease outcome [66]. In 
particular, the co-infection with porcine circovirus 
type 2 (PCV2) and the associated porcine circovirus 
diseases deserve special attention [61]. First evidence 
highlighted the high prevalence of TTSuV2 infection 
in postweaning multisystemic syndrome (PMWS), 
although in most cases, such co-infection does not lead 
to a disease; however, it is subclinical, suggesting that 
the disease association is possibly a matter of viral 
load [66]. Recent reports showed that porcine TTV 
partially contributed to inducing porcine reproductive 
and respiratory syndrome, porcine dermatitis and 
nephropathy syndrome, and hepatitis [82,83]. The 
latest research indicating that TTSuV2 but not 
TTSuV1 seems to benefit from the host’s disease 
status suggests that TTSuVs may act as triggers for 
diseases that cause immune system impairment. In this 
context, the level of TTSuV2 viremia may be 
associated with the level of immunocompetence of the 
animals, resulting in uncontrolled in PMWS animals, 
which are known to be immunocompromised [66]. 
Similarly, TTV DNA load in infected humans appears 
to correlate with the level of immune competence of 
the host [84,85]. Some authors have recently 
suggested that the expansion of members of AVs in 
the human microbiome and the increasing viral load in 
plasma during immunosuppressive therapy could be 
used to predict and monitor immune competence [86]. 
The association between the single infection with 
TTSuV or the co-infection with PCV2 and abortion in 
pigs has not been confirmed [16]. However, a recent 
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study carried out using pigs infected with the hepatitis 
E virus has shown a correlation between TTSuV and 
the increased risk of developing severe hepatitis in 
animals co-infected with PCV2 [87]. More recently, a 
high prevalence of TTSuV1, but not TTSuV2, in pigs 
suffering from porcine respiratory disease complex has 
been shown [88]. As for other porcine pathogens 
(PCV), it is therefore possible to speculate that the 
TTSuV species are distinct not only from the genetic 
point of view, but also for their different pathogenic 
potential. 
 
Conclusions 
Since their identification about 20 years ago, many 
studies have been conducted on human and animal 
TTVs, in order to assess the extent of dissemination of 
the infection and the pathogenic potential of the 
viruses [30,89]. It is likely that such viruses would be 
considered as components of the host microbiota and, 
as such, unable to cause disease directly, but rather 
available to be engaged in physiological processes and 
to modulate the response of the organism to other 
pathogens. It was recently suggested that the dynamics 
of replication of human TTVs can correlate with the 
immune competence of the host, and that the viral load 
can be considered as a possible biomarker of immune 
responsiveness [84]. It has been also proposed that 
animal AVs, especially TTSuVs, could be utilized as a 
model to evaluate the dynamics and the effects of 
global trade on viral heterogeneity, and to understand 
how live animal movement affects virus evolution 
[65]. Furthermore, it was hypothesized that TTV could 
be a more appropriate indicator of viral pathogens in 
drinking water than currently used indicator systems 
based solely on bacteria, thus providing an efficient 
indicator system for viral pathogen risk [90]. This 
indicator would have broad application to drinking 
water utilities and would provide a better means to 
assess viral risk and protect public health, especially in 
developing countries. Furthermore, TTSuV has been 
detected in commercial pig products including 
vaccines, enzymes for laboratory use, and human 
drugs containing components of porcine origin [13]. 
Such evidence would indicate the need to screen these 
products for the presence of these viruses. Finally, it 
has been reported that the prevalence of TTV is 
geographically variable. Could such a large variability 
influence the behavior of the infection at an individual 
level? Could the chronic exposure to this virus in a 
particular geographical area, especially in developing 
countries, be a source of repetitive pathogenicity for 
hosts? These and other epidemiological and biological 
aspects of animal AVs should be studied with large 
comparative and prospective studies. 
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